| Theme | For the Effective Eradication of Helicobactor pylori | |
|---|---|---|
| Title | Eradication Therapy for Helicobacter pylori in NSAIDs Ulcer | |
| Publish Date | 2001/06 | |
| Author | Shinichi Ota | Third Department of Internal Medicine, Saitama Medical School |
| Author | Hiromi Bamba | First Department of Internal Medicine, Saitama Medical Center, Saitama Medical School |
| Author | Yukinori Imai | Third Department of Internal Medicine, Saitama Medical School |
| Author | Shin Arai | Third Department of Internal Medicine, Saitama Medical School |
| Author | Kenji Fujiwara | Third Department of Internal Medicine, Saitama Medical School |
| [ Summary ] | About 50% of NSAIDs ulcer patients are infected with Helicobacter pylori. These patients could be treated through the eradication of this organism. However, the role of Helicobacter pylori in relation to NSAIDs ulcers has been controversial. While eradication of Helicobacter pylori prolonged the healing of gastric ulcers, this therapy dramatically reduced the incidence of these lesions. Detailed studies are required on this subject in Japan. | |